powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1871859728
Andrew Laccetti
M.D.
Hematology-Oncology
New York,
NY
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
PRESCRIBING · PART D · 2024
Total Rx claims
1,624
Beneficiaries
—
Total drug cost
$4.4M
Distinct drugs
15
Brand share
30.4%
Top prescribed drugs
Prednisone
488 claims
Abiraterone Acetate
428 claims
Relugolix
154 claims
Tamsulosin Hcl
124 claims
Enzalutamide
119 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
378
Unique beneficiaries
—
Total services
957
Distinct HCPCS
4
Medicare payment
$86K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 628 Hematology-Oncology providers in NY — above median (cohort median 883).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$2K
Payment records
5
By payment type
Consulting Fee
$1K
Food and Beverage
$314
Top paying entities
Consulting Fee
$1K
Food and Beverage
$314
QUALITY · MIPS · 2024
Final MIPS score
80.4
Quality
71.5
Cost
70.5
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.23%
Group
